Maximize Your Impact at ESC Congress 2025
ESC Congress 2025, taking place August 29 to September 1 at IFEMA Madrid in Spain, is one of the most influential events in global cardiology. Organized by the European Society of Cardiology, this annual gathering connects leading healthcare professionals, researchers, hospital executives, pharmaceutical leaders, and medtech innovators from around the world.
Decision-makers attending the event play a direct role in pharmaceutical partnerships, technology evaluations, clinical research collaborations, and hospital procurement. The environment is designed for high-value conversations, early-stage trials, and cross-sector alignment around the future of cardiovascular medicine.
The enriched attendee list from Vendelux provides full visibility into who is attending—from global KOLs and healthcare C-level executives to heads of R&D and procurement. Access to this intelligence early allows go-to-market teams to shape outreach plans, pursue strategic conversations, and approach the event with context and intent instead of cold introductions.
How Sales and Marketing Teams Can Use This Attendee List
ESC Congress attendees are highly specialized and often hold regional or global roles in purchasing, clinical development, market access, and digital health innovation. Use the enriched conference attendee list to map out accounts based on sector and responsibility, whether it’s targeting hospitals, pharma companies, academic institutions, or device manufacturers.
Segment outreach by company type—public hospitals, private clinics, global pharma, or health startups—and adapt messaging to match their goals in cardiovascular care. Whether you’re offering research platforms, digital therapeutics, patient management tools, or clinical software, aligning outreach to specific needs will increase engagement.
Connect early with those making budget decisions for new technologies or launching clinical partnerships. Outreach in the months before the event helps secure meetings with scientific and commercial leads who rarely respond to cold calls onsite. After the event, use the attendee data to move quickly on warm leads, reinforce shared interest, and grow initial conversations into long-term partnerships.
Timing Is Everything
ESC Congress 2025 will be held from August 29 to September 1, 2025. With thousands of specialized attendees representing hospitals, research institutions, and global healthcare companies, early engagement is key.
Begin outreach in May or June 2025 using the Vendelux attendee list to identify contacts and companies worth targeting. Plan meetings in alignment with attendee priorities for clinical results, partnership opportunity, and commercialization timelines. By reaching out early, your team can secure valuable time with decision-makers ahead of a tightly scheduled conference.
What’s Included in the ESC Congress 2025 Attendee List?
Vendelux provides an enriched attendee list that includes each contact’s first and last name, job title, company name, company website, location (city, state, and country), LinkedIn profile, and when available, verified email addresses and phone numbers. These details give your team the information they need to run relevant, timely campaigns around the event and follow up effectively afterward.
Where Is ESC Congress 2025?
ESC Congress 2025 will take place at IFEMA Madrid in Madrid, Comunidad de Madrid, Spain.
When Is ESC Congress 2025?
The event is scheduled for August 29 to September 1, 2025.
What Type of Event Is ESC Congress 2025?
ESC Congress is a scientific and medical conference focused on cardiovascular healthcare. It features clinical trial presentations, keynote lectures, industry symposia, and hands-on technology sessions. Attendees have multiple opportunities to network, discuss innovations, and initiate collaborations across the healthcare industry.
How Many People Attend ESC Congress 2025?
ESC Congress is expected to welcome over 30,000 attendees from more than 150 countries. The audience includes senior-level physicians, hospital executives, pharmaceutical leaders, and digital health experts, all with active decision-making responsibilities across research, procurement, and partnerships.
